SCHEMBL31593240

SCHEMBL31593240

Cc1c(NC(=O)c2cc(C3CC3)c(CO)cn2)cccc1-c1cccc(NC(=O)c2cc(C3CC3)c(CO)cn2)c1C

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PDCD1 Q15116 20/20 0.78
▸ CD274 Q9NZQ7 20/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22769830 1.00 PDCD1 (0.78) PDCD1CD274
SCHEMBL22675455 0.94 PDCD1 (0.70) PDCD1CD274
SCHEMBL24660093 0.90 PDCD1 (0.75) PDCD1CD274
SCHEMBL24660112 0.89 PDCD1 (0.79) PDCD1CD274
SCHEMBL30112663 0.88 PDCD1 (1.00) PDCD1CD274
SCHEMBL21229397 0.88 PDCD1 (1.00) PDCD1CD274
SCHEMBL30112668 0.87 PDCD1 (1.00) PDCD1CD274
SCHEMBL21229394 0.87 PDCD1 (1.00) PDCD1CD274
SCHEMBL22780114 0.87 PDCD1 (0.70) PDCD1CD274
SCHEMBL21229391 0.86 PDCD1 (1.00) PDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3750887-B1 BIARYL DERIVATIVES AND THEIR PHARMACEUTICAL APPLICATION FOR THE TREATMENT OF PD-1/PD-L1 SIGNAL PATHWAY-MEDIATED DISEASES ABBISKO THERAPEUTICS CO LTD (CN) 2025-05-28 — — EP disclosed
Send feedback